Current state data show why retail sales, patient counts, store networks and product volumes cannot be combined into one clean ranking of America’s largest cannabis markets.
The largest American cannabis markets are often placed in a single league table. State reporting makes that comparison look more precise than it is.
Adult-use regulators commonly publish gross retail sales. Medical-only programmes may publish active patients, dispensing events or quantities instead. Some states combine medical and adult-use sales in a single update. Tax treatment, visitor purchases, licence structure and reporting definitions vary. A ranking can be correct for one measure and misleading for another.
Current official figures from California, Illinois, New York, Florida, Pennsylvania and Oklahoma show the divide. They also show that the label attached to a programme does not, by itself, explain its competitive structure.
Adult-use markets count the checkout
California’s tax agency reported $956.7 million in cannabis sales subject to the excise tax during the first quarter of 2026. The same state dataset separately reported $1.15 billion in taxable sales, a broader figure that includes cannabis products and other tangible personal property reported by cannabis retailers. Even within one state, the selected definition changes the total.
Illinois reported $684.3 million in adult-use cannabis sales for the first half of 2026. Its table adds a dimension that medical programmes generally do not have: $133.2 million, nearly one-fifth of the total, came from out-of-state residents. Adult-use access allows visitor spending to become a measurable part of the legal market.
New York reported approximately $895.4 million in combined adult-use and medical retail sales through June 2026. Its update said average daily sales reached about $5.26 million in June while the open legal dispensary count reached 683 in early July and 705 on the state’s live list by August 6. New York’s number is useful for tracking its own expansion, but the combined total is not directly comparable with Illinois’ adult-use-only series.
These states define scale in dollars moving through regulated tills. The customer pool is all qualifying adults, subject to age and purchase rules, and may include non-residents. Store traffic is not dependent on maintaining a patient certification.
Medical markets count authorised access
Florida’s July 31 report listed 938,980 qualified patients with active identification cards and 771 dispensing locations. For one week, it reported 423.5 million milligrams of medical-marijuana THC and 146,369.661 ounces of marijuana in a form for smoking. It did not attach retail revenue to those quantities.
Pennsylvania’s June 2026 programme update reported 438,727 active patient certifications, 196 operational dispensaries and 33 operational growers and processors. It also reported $9.6 billion in sales since the programme began. The cumulative figure demonstrates substantial scale, but it cannot be compared with a six-month or quarterly adult-use number without aligning the time period.
Oklahoma’s August report listed 307,583 patients and 1,323 dispensaries. That works out to roughly one dispensary for every 233 licensed patients, a much denser door-to-patient relationship than Pennsylvania or Florida. Oklahoma’s commercial count reflects its historically permissive entry model and the long contraction that followed; it does not mean its patients spend more.
Medical-market size therefore has at least four legitimate definitions: authorised patients, active certifications, dispensing locations and regulated sales or product volume. A state can lead on one and not another. Florida’s patient base is more than twice Pennsylvania’s active-certification count, while Pennsylvania provides a long-run dollar figure that Florida’s weekly public report does not.
Access rules change the addressable market
An adult-use retailer can generally serve any adult who meets the state’s age and identification requirements. That makes population, tourism, border traffic and local store access central demand variables. Illinois’ separate reporting for residents and non-residents makes the border effect explicit.
A medical retailer serves a gated population. Florida patients need a physician order and an active registry card. Pennsylvania reports active certifications. Oklahoma requires a patient licence. Registration fees, renewal cycles, physician availability, qualifying-condition rules and residency requirements all shape the addressable customer base before a store competes for a sale.
That difference affects interpretation of store counts. Seven hundred adult-use stores in a state do not serve the same potential audience as seven hundred medical dispensaries. The former may reach most adults and visitors; the latter divide a defined patient registry.
The supply-chain model matters as much as the programme label
Florida is medical-only and vertically integrated: each treatment-centre licensee cultivates, processes, transports and dispenses. Its 771 locations sit behind 28 treatment-centre licences.
Oklahoma is also medical-only, but its August 2026 report separately counted 1,801 growers, 587 processors and 1,323 dispensaries. The state has imposed a moratorium on new licences, yet the surviving supply chain remains structurally different from Florida’s.
Adult-use states vary just as widely. New York separates cultivation, processing, distribution and retail while also licensing microbusinesses. California licenses multiple supply-chain roles and publishes both track-and-trace and tax data. The adult-use/medical divide determines who may buy, but it does not determine whether the market is open, capped or vertically integrated.
Taxes and prices distort simple rankings
Reported sales can include or exclude excise tax, sales tax and non-cannabis merchandise. California’s open-data table explicitly distinguishes cannabis sales from taxable sales. Illinois said its 2026 table uses actual sales receipts after identifying that its earlier seed-to-sale reporting had reflected non-discounted prices. New York’s annual report tracked declining average unit prices as the licensed store network expanded.
That means a falling dollar total can reflect lower prices even when more units are sold. A rising total can reflect new stores, higher prices, more customers or a reporting change. Patient counts have their own limitation: an active card is permission to purchase, not proof of a transaction.
A better way to describe the largest markets
A defensible comparison should name the measure and period every time. California was a roughly $957 million excise-tax sales market in the first quarter of 2026. Illinois sold $684 million of adult-use cannabis in the first half. Florida had about 939,000 active cardholders at the end of July. Pennsylvania had about 439,000 active certifications and $9.6 billion in programme-to-date sales as of June 1. Oklahoma had about 308,000 patients and 1,323 dispensaries in its August report.
Those statements can coexist without being forced into a false national ranking. They answer different questions: where the most dollars were reported, where the largest authorised patient population lives, where retail access is densest, and where a programme has accumulated the most sales over time.
The practical lesson for operators is that a large market is not simply a large number. It is a specific combination of eligible customers, licensed doors, supply-chain rules, prices, taxes and reporting definitions. Adult-use and medical markets differ most clearly at the customer gate. Everything after that depends on the state.